Idorsia Future Growth
Future criteria checks 2/6
Idorsia is forecast to grow earnings and revenue by 16.9% and 24.2% per annum respectively while EPS is expected to grow by 37.9% per annum.
Key information
16.9%
Earnings growth rate
37.9%
EPS growth rate
Biotechs earnings growth | 21.3% |
Revenue growth rate | 24.2% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 24 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 452 | -226 | N/A | -219 | 5 |
12/31/2025 | 261 | -347 | -379 | -354 | 7 |
12/31/2024 | 226 | -489 | -460 | -446 | 8 |
12/31/2023 | 126 | -407 | -361 | -483 | 8 |
9/30/2023 | 185 | -374 | -751 | -739 | N/A |
6/30/2023 | 126 | -814 | -874 | -859 | N/A |
3/31/2023 | 113 | -843 | -889 | -871 | N/A |
12/31/2022 | 97 | -828 | -886 | -859 | N/A |
9/30/2022 | 48 | -887 | -868 | -836 | N/A |
6/30/2022 | 44 | -810 | -788 | -756 | N/A |
3/31/2022 | 34 | -728 | -719 | -678 | N/A |
12/31/2021 | 35 | -635 | -621 | -590 | N/A |
9/30/2021 | 36 | -520 | -542 | -515 | N/A |
6/30/2021 | 27 | -499 | -513 | -491 | N/A |
3/31/2021 | 74 | -429 | -419 | -409 | N/A |
12/31/2020 | 72 | -445 | -374 | -365 | N/A |
9/30/2020 | 70 | -450 | -379 | -367 | N/A |
6/30/2020 | 69 | -451 | -417 | -400 | N/A |
3/31/2020 | 22 | -507 | -478 | -459 | N/A |
12/31/2019 | 24 | -494 | -481 | -462 | N/A |
9/30/2019 | 61 | -460 | -479 | -461 | N/A |
6/30/2019 | 61 | -459 | -445 | -430 | N/A |
3/31/2019 | 61 | -414 | -404 | -391 | N/A |
12/31/2018 | 61 | -386 | -367 | -353 | N/A |
9/30/2018 | 209 | -213 | -81 | -63 | N/A |
6/30/2018 | 203 | -165 | -39 | -25 | N/A |
12/31/2017 | 190 | -17 | 105 | 115 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IDRS.F is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: IDRS.F is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: IDRS.F is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: IDRS.F's revenue (24.2% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: IDRS.F's revenue (24.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if IDRS.F's Return on Equity is forecast to be high in 3 years time